Increased plasma glutamate, glycine, and arginine levels in complex regional pain syndrome type 1

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 5, 2008, Pages 688-694

  Wesseldijk, F ^a   Fekkes, D ^a   Huygen, F J P M ^a   Van De Heide Mulder, M ^a   Zijlstra, F J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Arginine; Complex regional pain syndrome type 1; Glutamate; Glutamine; Pain; VAS

Indexed keywords

AMINO ACID; ARGININE; CITRULLINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; ORNITHINE; PHENYLALANINE; SERINE; TAURINE; TRYPTOPHAN; TYROSINE; VALINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; COMPLEX REGIONAL PAIN SYNDROME TYPE I; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MCGILL PAIN QUESTIONNAIRE; PAIN ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; PSYCHOLOGICAL ASPECT; VISUAL ANALOG SCALE;

AMINO ACIDS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PAIN MEASUREMENT; QUALITY OF LIFE; REFLEX SYMPATHETIC DYSTROPHY; STATISTICS, NONPARAMETRIC; TAURINE;

EID: 42249098850     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2008.01638.x     Document Type: Article

References (39)

1. Janig W, Baron R. Is CRPS I a neuropathic pain syndrome? Pain 2006 120 : 227 9.
2. Birklein F, Schmelz M, Schifter S et al. The important role of neuropeptides in complex regional pain syndrome. Neurology 2001 57 : 2179 84.
3. Huygen FJ, de Bruijn AG, Klein J et al. Neuroimmune alterations in the complex regional pain syndrome. Eur J Pharmacol 2001 429 : 101 13.
4. Huygen FJ, de Bruijn AG, de Bruin MT et al. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm 2002 11 : 47 51.
5. Heijmans-Antonissen C, Wesseldijk F, Munnikes RJ et al. Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1. Mediators Inflamm 2006 2006 : 28398.
6. Birklein F. Complex regional pain syndrome. J Neurol 2005 252 : 131 8.
7. Correll GE, Maleki J, Gracely EJ et al. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med 2004 5 : 263 75.
8. Goldberg ME, Domsky R, Scaringe D et al. Multi-day low dose ketamine infusion for the treatment of complex regional pain syndrome. Pain Physician 2005 8 : 175 9.
9. Villanueva-Perez VL, Cerda-Olmedo G, Samper JM et al. Oral ketamine for the treatment of type I complex regional pain syndrome. Pain Pract 2007 7 : 39 43.
10. Koffler SP, Hampstead BM, Irani F et al. The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome. Arch Clin Neuropsychol 2007 22 : 719 29.
11. Schattschneider J, Hartung K, Stengel M et al. Endothelial dysfunction in cold type complex regional pain syndrome. Neurology 2006 67 : 673 5.
12. Groeneweg JG, Huygen FJ, Heijmans-Antonissen C et al. Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1. BMC Musculoskelet Disord 2006 7 : 91 (1-8).
13. Alexander GM, Perreault MJ, Reichenberger ER et al. Changes in immune and glial markers in the CSF of patients with complex regional pain syndrome. Brain Behav Immunol 2007 21 : 668 76.
14. Bruehl S, Harden RN, Galer BS et al. External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain. Pain 1999 81 : 147 54.
15. Fekkes D, van Dalen A, Edelman M et al. Validation of the determination of amino acids in plasma by high-performance liquid chromatography using automated pre-column derivatization with o-phthaldialdehyde. J Chromatogr B Biomed Appl 1995 669 : 177 86.
16. Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms, 2nd edn. Seattle, WA : IASP Press, 1994 : 40 3.
17. Lowe NK, Walker SN, McCallum RC. Confirming the theoretical structure of the McGill Pain Questionnaire in acute clinical pain. Pain 1991 46 : 53 60.
18. Arrindell WA, Ettema H. The Dutch version of the Symptom Checklist (SCL-90). Ned Tijdsch Psych [Dutch J Psychol] 1981 36 : 77 108.
19. Geertsen JHB, de Bruijn-Kofman AT, de Bruijn HP et al. Stressful life events and psychological dysfunction in complex regional pain syndrome type 1. Clin J Pain 1998 14 : 143 7.
20. Curthoys NP, Watford M. Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 1995 15 : 133 59.
21. Peng X, Yan H, You Z et al. Glutamine granule-supplemented enteral nutrition maintains immunological function in severely burned patients. Burns 2006 32 : 589 93.
22. Castillo J, Davalos A, Noya M. Progression of ischaemic stroke and excitotoxic aminoacids. Lancet 1997 349 : 79 83.
23. Alam Z, Coombes N, Waring RH et al. Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache. J Neurol Sci 1998 156 : 102 6.
24. Vaccaro M, Riva C, Tremolizzo L et al. Platelet glutamate uptake and release in migraine with and without aura. Cephalalgia 2007 27 : 35 40.
25. Peres MF, Zukerman E, Senne Soares CA et al. Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia 2004 24 : 735 9.
26. Mitani H, Shirayama Y, Yamada T et al. Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuropsychopharmacol Biol Psychiatr 2006 30 : 1155 8.
27. Rommel O, Willweber-Strumpf A, Wagner P et al. Psychological abnormalities in patients with complex regional pain syndrome (CRPS). Schmerz 2005 19 : 272 84.
28. Schilling T, Eder C. A novel physiological mechanism of glycine-induced immunomodulation: Na+-coupled amino acid transporter currents in cultured brain macrophages. J Physiol 2004 559 : 35 40.
29. Jorum E, Warncke T, Stubhaug A. Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-d-aspartate (NMDA) receptor antagonist ketamine - a double-blind, cross-over comparison with alfentanil and placebo. Pain 2003 101 : 229 35.
30. Poyhia R, Vainio A. Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia. Clin J Pain 2006 22 : 32 6.
31. Sessa WC, Hecker M, Mitchell JA et al. The metabolism of l-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: l-glutamine inhibits the generation of l-arginine by cultured endothelial cells. Proc Natl Acad Sci USA 1990 87 : 8607 11.
32. Fekkes D, Bannink M, Kruit WHJ et al. Influence of pegylated interferon-α therapy on plasma levels of citrulline and arginine in melanoma patients. Amino Acids 2007 32 : 121 6.
33. Wasner G, Schattschneider J, Heckmann K et al. Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value. Brain 2001 124 : 587 99.
34. Saransaari P, Oja SS. Characteristics of taurine release induced by free radicals in mouse hippocampal slices. Amino Acids 2004 26 : 91 8.
35. Zhang M, Izumi I, Kagamimori S et al. Role of taurine supplementation to prevent exercise-induced oxidative stress in healthy young men. Amino Acids 2004 26 : 203 7.
36. Pellicer F, Lopez-Avila A, Coffeen U et al. Taurine in the anterior cingulate cortex diminishes neuropathic nociception: a possible interaction with the glycine(A) receptor. Eur J Pain 2007 11 : 444 51.
37. Hilgier W, Anderzhanova E, Oja SS et al. Taurine reduces ammonia- and N-methyl-d-aspartate-induced accumulation of cyclic GMP and hydroxyl radicals in microdialysates of the rat striatum. Eur J Pharmacol 2003 468 : 21 5.
38. Bellows CF, Jaffe BM. Glutamine is essential for nitric oxide synthesis by murine macrophages. J Surg Res 1999 86 : 213 9.
39. Luiking YC, Deutz NE. Isotopic investigation of nitric oxide metabolism in disease. Curr Opin Clin Nutr Metab Care 2003 6 : 103 8.